The new solution employs AI and NLP to sift through vast amounts of EMR data. Credit: Michal Jarmoluk from Pixabay.

Precision research platform Deep 6 AI has partnered with Graticule to develop a new algorithm designed to expedite patient screening and recruitment for clinical trials.

The “first-of-its-kind” solution employs artificial intelligence (AI) and natural language processing (NLP) to sift through vast amounts of electronic medical record (EMR) data.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

It identifies eligible patients by extracting critical information from both structured and unstructured data sources, such as clinical notes and radiology reports.

The screening algorithm will then qualify and prioritise eligible subjects using the insights to give a precise picture of the individuals who would benefit from the intervention.

Graticule chief technology officer Dan Housman said: “Traditionally, it takes up to two years for life sciences companies to get access to EMR data to develop novel patient matching algorithms.

See Also:

“Additionally, traditional methods of ‘clinical data pulling’ often burden an already overworked hospital IT staff. We partnered with Deep 6 AI to accelerate the development and deployment of screening tools that reduce site burden through access to ready-to-use deep EMR data from 1K+ research facilities across the Deep 6 AI ecosystem.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Coupled with quick implementation services, the algorithm is being piloted actively at sites in the research ecosystem of Deep 6 AI for expediting trial completion.

Deep 6 AI founder and CEO Wout Brusselaers said: “We help clinical research teams identify targeted patient populations with great precision and speed by using AI to mine deeper data that goes beyond traditional claims and structured EMR data.

“By applying Graticule’s real-world data research methods and advisory services to the real-time, real patient data within our research ecosystem, we have drastically improved the utility of the research algorithms and screening processes we offer.”